Drugs / polygonum cuspidatum extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01489319 | Feb 2012 → Jun 2015 | polycystic ovary syndrome | Indiana University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polygonum cuspidatum extract | “salsalate and polygonum cuspidatum extract (PCE) containing resveratrol” NCT01489319 ↗ |
| Known as | PCE | “salsalate and polygonum cuspidatum extract (PCE) containing resveratrol” NCT01489319 ↗ |